Prevalence of Hypertrophic Cardiomyopathy in Fetuses of Mothers with Gestational Diabetes before Initiating Treatment

ABSTRACT Objective: To evaluate the prevalence of hypertrophic cardiomyopathy (HCM) in fetuses of pregnant women with gestational diabetes mellitus (GDM) in the beginning of the treatment. Methods: A cross-sectional study was performed between July 1, 2013, and Decem-ber 20, 2013, in a public mat...

Full description

Bibliographic Details
Main Authors: Carolina Rossi Palmieri, Mona Adalgisa Simões, Jean Carl Silva, Anelise Darabas dos Santos, Mariana Ribeiro e Silva, Bruna Ferreira
Format: Article
Language:English
Published: Federação Brasileira das Sociedades de Ginecologia e Obstetrícia 2017-01-01
Series:Revista Brasileira de Ginecologia e Obstetrícia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032017000100009&tlng=en
_version_ 1818752591908044800
author Carolina Rossi Palmieri
Mona Adalgisa Simões
Jean Carl Silva
Anelise Darabas dos Santos
Mariana Ribeiro e Silva
Bruna Ferreira
author_facet Carolina Rossi Palmieri
Mona Adalgisa Simões
Jean Carl Silva
Anelise Darabas dos Santos
Mariana Ribeiro e Silva
Bruna Ferreira
author_sort Carolina Rossi Palmieri
collection DOAJ
description ABSTRACT Objective: To evaluate the prevalence of hypertrophic cardiomyopathy (HCM) in fetuses of pregnant women with gestational diabetes mellitus (GDM) in the beginning of the treatment. Methods: A cross-sectional study was performed between July 1, 2013, and Decem-ber 20, 2013, in a public maternity clinic in southern Brazil. The subjects were 63 fetuses of mothers with gestational diabetes, with a single pregnancy and no other associated pathologies. We diagnosed HCM through a fetal echocardiography before treatment and evaluated the maternal and fetal characteristics. Results: The average age of the pregnant women was 32.32 (±6.2) years, and the average gestational age at the time of the evaluation was 30.59 (±2.27) weeks. The interventricular septum thickness showed a standard deviation of more than two in 50.8% of the fetuses (95% confidence interval [95%CI]: 38.1-63.5%). The left ventricular wall thickness showed a standard deviation of more than 2 in 13 (20.6%) fetuses (95%CI: 11.1-30.2%). The HCM was confirmed in 54% of the fetuses (95%CI: 41.3-65.1%). The fetal abdominal circumference was normal in 46 (73%) fetuses, and 50% of these fetuses had HCM. Conclusion: The prevalence of hypertrophic cardiomyopathy in fetuses of pregnant women with GDM before treatment was of 54% (95%CI: 41.3-65.1%).
first_indexed 2024-12-18T04:53:54Z
format Article
id doaj.art-d0a8c20da1434a9da421f1f8d1df296c
institution Directory Open Access Journal
issn 0100-7203
language English
last_indexed 2024-12-18T04:53:54Z
publishDate 2017-01-01
publisher Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
record_format Article
series Revista Brasileira de Ginecologia e Obstetrícia
spelling doaj.art-d0a8c20da1434a9da421f1f8d1df296c2022-12-21T21:20:21ZengFederação Brasileira das Sociedades de Ginecologia e ObstetríciaRevista Brasileira de Ginecologia e Obstetrícia0100-72032017-01-0139191310.1055/s-0037-1598602Prevalence of Hypertrophic Cardiomyopathy in Fetuses of Mothers with Gestational Diabetes before Initiating TreatmentCarolina Rossi PalmieriMona Adalgisa SimõesJean Carl SilvaAnelise Darabas dos SantosMariana Ribeiro e SilvaBruna FerreiraABSTRACT Objective: To evaluate the prevalence of hypertrophic cardiomyopathy (HCM) in fetuses of pregnant women with gestational diabetes mellitus (GDM) in the beginning of the treatment. Methods: A cross-sectional study was performed between July 1, 2013, and Decem-ber 20, 2013, in a public maternity clinic in southern Brazil. The subjects were 63 fetuses of mothers with gestational diabetes, with a single pregnancy and no other associated pathologies. We diagnosed HCM through a fetal echocardiography before treatment and evaluated the maternal and fetal characteristics. Results: The average age of the pregnant women was 32.32 (±6.2) years, and the average gestational age at the time of the evaluation was 30.59 (±2.27) weeks. The interventricular septum thickness showed a standard deviation of more than two in 50.8% of the fetuses (95% confidence interval [95%CI]: 38.1-63.5%). The left ventricular wall thickness showed a standard deviation of more than 2 in 13 (20.6%) fetuses (95%CI: 11.1-30.2%). The HCM was confirmed in 54% of the fetuses (95%CI: 41.3-65.1%). The fetal abdominal circumference was normal in 46 (73%) fetuses, and 50% of these fetuses had HCM. Conclusion: The prevalence of hypertrophic cardiomyopathy in fetuses of pregnant women with GDM before treatment was of 54% (95%CI: 41.3-65.1%).http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032017000100009&tlng=engestational diabetesfetal echocardiographyfetusheart diseaseshypertrophic cardiomyopathy
spellingShingle Carolina Rossi Palmieri
Mona Adalgisa Simões
Jean Carl Silva
Anelise Darabas dos Santos
Mariana Ribeiro e Silva
Bruna Ferreira
Prevalence of Hypertrophic Cardiomyopathy in Fetuses of Mothers with Gestational Diabetes before Initiating Treatment
Revista Brasileira de Ginecologia e Obstetrícia
gestational diabetes
fetal echocardiography
fetus
heart diseases
hypertrophic cardiomyopathy
title Prevalence of Hypertrophic Cardiomyopathy in Fetuses of Mothers with Gestational Diabetes before Initiating Treatment
title_full Prevalence of Hypertrophic Cardiomyopathy in Fetuses of Mothers with Gestational Diabetes before Initiating Treatment
title_fullStr Prevalence of Hypertrophic Cardiomyopathy in Fetuses of Mothers with Gestational Diabetes before Initiating Treatment
title_full_unstemmed Prevalence of Hypertrophic Cardiomyopathy in Fetuses of Mothers with Gestational Diabetes before Initiating Treatment
title_short Prevalence of Hypertrophic Cardiomyopathy in Fetuses of Mothers with Gestational Diabetes before Initiating Treatment
title_sort prevalence of hypertrophic cardiomyopathy in fetuses of mothers with gestational diabetes before initiating treatment
topic gestational diabetes
fetal echocardiography
fetus
heart diseases
hypertrophic cardiomyopathy
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032017000100009&tlng=en
work_keys_str_mv AT carolinarossipalmieri prevalenceofhypertrophiccardiomyopathyinfetusesofmotherswithgestationaldiabetesbeforeinitiatingtreatment
AT monaadalgisasimoes prevalenceofhypertrophiccardiomyopathyinfetusesofmotherswithgestationaldiabetesbeforeinitiatingtreatment
AT jeancarlsilva prevalenceofhypertrophiccardiomyopathyinfetusesofmotherswithgestationaldiabetesbeforeinitiatingtreatment
AT anelisedarabasdossantos prevalenceofhypertrophiccardiomyopathyinfetusesofmotherswithgestationaldiabetesbeforeinitiatingtreatment
AT marianaribeiroesilva prevalenceofhypertrophiccardiomyopathyinfetusesofmotherswithgestationaldiabetesbeforeinitiatingtreatment
AT brunaferreira prevalenceofhypertrophiccardiomyopathyinfetusesofmotherswithgestationaldiabetesbeforeinitiatingtreatment